Literature DB >> 29504521

Relationship of work disability between the disease activity, depression and quality of life in patients with ankylosing spondylitis.

Sinem Sağ, Kemal Nas, Mustafa Serdar Sağ, İbrahim Tekeoğlu, Ayhan Kamanlı.   

Abstract

OBJECTIVES: In this study, our objective was to determine the work productivity and work disability of the patients with ankylosing spondylitis (AS) and to investigate the relation of these parameters with disease activity, anxiety, depression and quality of life. PATIENTS AND METHODS: Fifty patients with the diagnosis of AS and 30 healthy control were included in the study. In patients with AS, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) was used to evaluate the disease activity; Bath Ankylosing Spondylitis Metrology Index (BASMI) was used to evaluate the spinal mobility and Bath Ankylosing Spondylitis Functional Index (BASFI) was used to determine the functional status. In addition, the Ankylosing Spondylitis Quality of Life (ASQoL) questionnaire and The Short Form (SF-36) Health Survey was used to evaluate the health status, Hospital Anxiety and Depression Scale (HADS) was used for the evaluation of depression and anxiety and Work Productivity and Activity Impairment Questionnaire: Specific Health Problem v2.0 (WPAI:SHP) was used to evaluate the work productivity.
RESULTS: In AS patients duration of disease at the diagnosis was 7.24 ± 6.23 years. The time lost at work due to the disease, decrease in the work productivity and impairment in the time off daily activities were worse in the patient group compared with the control group (p< 0.05). The impairment in the work productivity was correlated with BASDAI and depression; difficulty in time-off activities was correlated with BASFI and anxiety and depression was correlated with BASDAI (p< 0.05). While the impairment in work productivity was correlated with the subparameter vitality in SF-36, difficulty in time off activities was correlated with general health status, social functions, vitality and mental health (p< 0.05).
CONCLUSION: In this study, we determined that AS had a significant influence on the working conditions and the factors related to the disease had a significant correlation with work productivity. Factors related to the psychology and the disease were also correlated with the working conditions.

Entities:  

Keywords:  Ankylosing spondylitis; quality of life; work disability

Mesh:

Year:  2018        PMID: 29504521     DOI: 10.3233/BMR-169657

Source DB:  PubMed          Journal:  J Back Musculoskelet Rehabil        ISSN: 1053-8127            Impact factor:   1.398


  7 in total

1.  [Functional outcomes of patients receiving total hip arthroplasty for ankylosing spondylitis].

Authors:  Wenrui Wu; Simin Luo; Ning Liu; Zhengang Zha
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-07-30

2.  Work productivity impairment in patients with familial Mediterranean fever and effects of interleukin-1 antagonists.

Authors:  Erdem Suticen; Nuh Atas; Aslihan Avanoglu Guler; Orhun Akdogan; Hakan Babaoğlu; Hasan Satis; Hazan Karadeniz; Seminur Haznedaroglu; Mehmet Akif Ozturk; Abdurrahman Tufan
Journal:  Clin Rheumatol       Date:  2021-02-01       Impact factor: 2.980

3.  Factors associated with depressive symptoms in patients with ankylosing spondylitis in Northern Taiwan.

Authors:  Mei-Ling Fang; Chien-Sheng Wu; Li-Chueh Weng; Hsiu-Li Huang
Journal:  PLoS One       Date:  2019-10-24       Impact factor: 3.240

4.  Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated With Adalimumab in China.

Authors:  Liudan Tu; Ya Xie; Zetao Liao; Yutong Jiang; Qing Lv; Shuangyan Cao; Qiujing Wei; Jieruo Gu
Journal:  Front Public Health       Date:  2020-11-24

5.  Objective Measurements of Physical Activity and Sedentary Behavior Using Wearable Devices in Patients With Axial Spondyloarthritis: Protocol for a Systematic Review.

Authors:  Thomas Carlin; Julie Soulard; Timothée Aubourg; Johannes Knitza; Nicolas Vuillerme
Journal:  JMIR Res Protoc       Date:  2021-11-25

Review 6.  Efficacy and safety of interleukin-17A inhibitors in patients with ankylosing spondylitis: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Peng Wang; Shuo Zhang; Binwu Hu; Weijian Liu; Xiao Lv; Songfeng Chen; Zengwu Shao
Journal:  Clin Rheumatol       Date:  2021-01-12       Impact factor: 2.980

7.  Active ankylosing spondylitis increases blood loss during total hip arthroplasty for a stiff hip joint.

Authors:  Yong Hu; Wei-Zhou Jiang; Cheng-Long Pan; Tao Wang
Journal:  BMC Musculoskelet Disord       Date:  2020-04-15       Impact factor: 2.362

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.